|
1.
Tamoxifen for early breast cancer: An overview of the randomised
trials. Early Breast Cancer Trialists ’Collaborative
Group. Lancet 1998;351(9114):1451-67. Abstract
2. Kemeny
M et al. Barriers to participation of older women with
breast cancer in clinical trials. Proc ASCO 2000;
Abstract
2371.
3. Gail
MH et al. Weighing the risks and benefits of tamoxifen
treatment for preventing breast cancer. J Natl Cancer
Inst 1999;91(21):1829-46. Abstract
4. Blum
JL, Jones SE, Buzdar AU et al. Multicenter phase II study
of
capecitabine in paclitaxel-refractory metastatic breast cancer.
J Clin Oncol 1999;17:485-93. Abstract
5.Cervantes
G et al. Capecitabine (Xeloda) as treatment after failure
to
taxanes for metastatic breast cancer. Proc ASCO
2000; Abstract469.
6.Kusama
M et al. A phase II study of Xeloda ™ (capecitabine)
in patients with advanced/metastatic breast carcinoma —
The Cooperative Study Group of Capecitabine for Breast Carcinoma.
Proc ASCO 2001; Abstract
1924.
7.Thuss-Patience
PC et al. Capecitabine:A new standard in metastatic breast
cancer recurring after anthracycline and taxane-containing
chemotherapy? Results of a multicenter phase II trial.Proc
ASCO 2001; Abstract
2012.
8.O ’Shaughnessy
J et al. A randomized phase II study of XelodaTM (capecitabine)
vs CMF as first-line chemotherapy of breast cancer in women
aged 55 years. Proc ASCO 1998; Abstract
398.
9.Balducci
L. The geriatric cancer patient:Equal benefit from equal
treatment. Cancer Control 2001;8(2 Suppl):1-25.
Full-Text
10.Crivellari
D et al. Burdens and benefits of adjuvant cyclophosphamide,
methotrexate,and fluorouracil and tamoxifen for elderly patients
with breast cancer: The International Breast Cancer Study
Group Trial VII. J Clin Oncol 2000;18:1412-22.
Abstract
11.Diab
SG et al. Tumor characteristics and clinical outcome of
elderly women with breast cancer. J Natl Cancer Inst
2000;92:550-6. Abstract
12.Du
X,Goodwin JS. Patterns of use of chemotherapy for breast
cancer in older women:Findings from Medicare claims data.
J Clin Oncol 2001;19:1455-61. Abstract
OTHER
CLINICAL TRIALS
SWS-SAKK-25/99;EU-99007:
Phase I/II Study of Capecitabine and
Vinorelbine in Elderly Women with Metastatic Breast Cancer
with or
without Bone Involvement. Protocol
|
